Research Article Open Access Double-Blind Peer Review

INTEGRATING TRADITIONAL CHINESE MEDICINE IN LUNG CANCER CARE

Li Mingyu·Wang Xiaohui
Published 28 January 2025
Vol. 11, No. 3 (2023)
pp. 12-22
CC BY 4.0
  1. 1
    Li Mingyu
    Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
    CN
  2. 2
    Wang Xiaohui
    Shaanxi Provincial Hospital of Chinese Medicine, Xi'an, Shaanxi, 710003, China
    CN

Lung cancer is a significant health concern in China, and its high incidence and mortality rates necessitate effective treatment strategies. Traditional treatments, including surgical resection, radiotherapy, and chemotherapy, have their limitations and often come with unwanted side effects. More recently, targeted therapies and immunotherapies have emerged, but they still face challenges like drug resistance and unpredictable side effects. Chinese medicine, with its long history and holistic approach, has demonstrated positive effects in lung cancer treatment. Research has indicated that it can not only enhance the prognosis but also improve patients' quality of life. In this article, we delve into the complex landscape of lung cancer treatment and explore the role of Chinese medicine. We assess its potential to address some of the shortcomings of modern medical interventions, offering a more comprehensive and personalized approach to patient care. Our aim is to bridge the gap between traditional and contemporary treatments, providing a more effective and holistic strategy for managing this deadly disease.

JournalColumbia Journal of Medical Research and Practice
ISSN3065-0631
Volume / IssueVol. 11, No. 3 (2023)
Pages12-22
Published28 January 2025
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Mingyu, L., Xiaohui, W. (2025). INTEGRATING TRADITIONAL CHINESE MEDICINE IN LUNG CANCER CARE. Columbia Journal of Medical Research and Practice, Vol. 11 No. 3, pp. 12-22

 Submit Your Research to Columbia Journal of Medical Research and Practice

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.